Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Lack of Effect of Coenzyme Q10 on Coumarin-induced Hypoprothrombinæmia

Abstract

SEVERAL coumarin and indanedione drugs are capable of inducing hypoprothrombinæmia, presumably by interfering with the cofactor role of vitamin K in prothrombin synthesis. This role of vitamin K, probably involving electron transport, can be competitively inhibited by coumarins, and the inhibition competitively overcome by large doses of vitamin K (ref. 1).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Link, K. P., Harvey Lectures, 39, 162 (1944).

    Google Scholar 

  2. Green, D. M., and Lester, R. L., Fed. Proc., 18, 987 (1959).

    CAS  PubMed  Google Scholar 

  3. Sastry, P. S., Jayaraman, J., and Ramasarma, T., Nature, 189, 577 (1961).

    Article  ADS  CAS  Google Scholar 

  4. Chenkin, T., Dayton, P. G., Weisberg, L. G., and Weiner, M., Exp. Med. and Surg., 17, 219 (1960).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

WEINER, M., CHENKIN, T. & DAYTON, P. Lack of Effect of Coenzyme Q10 on Coumarin-induced Hypoprothrombinæmia. Nature 191, 711 (1961). https://doi.org/10.1038/191711a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/191711a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing